Combining insulin and sulfonylurea
- 1 August 1992
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 92 (2) , 89-102
- https://doi.org/10.1080/00325481.1992.11701418
Abstract
Non-insulin-dependent (type II) diabetes mellitus is a progressive disease that requires sequential therapy to achieve optimal control. When diet and sulfonylurea fail to maintain glycemic control, the addition of a single daily injection of insulin may be indicated. The best candidates for this combined therapy are patients with typical adult-onset disease that has been present less than 10 to 15 years.Keywords
This publication has 11 references indexed in Scilit:
- Combined Therapy for Obese Type 2 Diabetes: Suppertime Mixed Insulin with Daytime SulfonylureaThe Lancet Healthy Longevity, 1992
- Insulin plus a Sulfonylurea Agent for Treating Type 2 DiabetesAnnals of Internal Medicine, 1991
- Evening Insulin StrategyDiabetes Care, 1990
- Combination Insulin-Sulfonylurea TherapyDiabetes Care, 1990
- Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic SubjectsDiabetes Care, 1989
- Combined Insulin-Sulfonylurea Treatment of Type II DiabetesThe Diabetes Educator, 1989
- Effects of Combined Insulin-Sulfonylurea Therapy in type II PatientsDiabetes Care, 1989
- Addition of Sulfonylurea to Insulin Treatment in Poorly Controlled Type II DiabetesPublished by American Medical Association (AMA) ,1987
- Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin WithdrawalDiabetes, 1984
- A Hypocaloric High-Protein Diet as Primary Therapy for Adults with Obesity-related Diabetes: Effective Long-Term Use in a Community HospitalDiabetes Care, 1983